Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1765-2020Class II

System AXIOM Aristos FX Plus - A dedicated x-ray system with a flat panel detector which allows the...

Siemens Medical Solutions USA, Inc. / initiated 2020-04-06 / Terminated

Siemens Medical Solutions USA, Inc began a recall of System AXIOM Aristos FX Plus - A dedicated x-ray system with a flat panel detector which allows the acquisition of x-ray exposures without the use of... on . FDA classified it as Class II and gives the reason as "It was determined that in rare cases persons can receive low dose of unintended radiation. The system performed exposures without the exposure button being pressed. Exposure will be released for less than 500ms...". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1765-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Medical Solutions USA, Inc.
Product
System AXIOM Aristos FX Plus - A dedicated x-ray system with a flat panel detector which allows the acquisition of x-ray exposures without the use of conventional film/screen systems; and allows radiographic exposures of the whole body including skull, spinal column, chest, abdomen, and extremities. It is not designed for mammography use. Radiographic exposures may be taken with the patient in the sitting, standing, or supine positions.
Product code
MQB Solid State X-Ray Imager (Flat Panel/Digital Imager)
Reason for recall
It was determined that in rare cases persons can receive low dose of unintended radiation. The system performed exposures without the exposure button being pressed. Exposure will be released for less than 500ms, therefore, the overall dose is estimated at 0.01mSv or less than 500 mGy in total.
FDA root cause
Radiation Control for Health and Safety Act
Action
Only one user in the United States is affected by this corrective action. The Customer Safety Advisory Notice was sent to the affected customer. Any additional communication regarding this corrective action will include the following statement: The manufacturer will, without charge, remedy the defect or bring the product into compliance with each applicable Federal standard in accordance with a plan to be approved by the Secretary of Health and Human Services, the details of which will be included
Quantity in commerce
399 (wordwide)
Distribution
Worldwide Distribution
Product codes and lots
serail number 1192

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1765-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1764-2020Class IITerminatedFDA Mandated
Z-1765-2020Class IITerminatedFDA Mandated